- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer Vaccines Co-Targeting HER2/Neu and IGF1R
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 4, Pages 517
Publisher
MDPI AG
Online
2019-04-12
DOI
10.3390/cancers11040517
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis
- (2019) Carla De Giovanni et al. BMC CANCER
- Insulin-Like Growth Factor (IGF) Pathway Targeting in Cancer: Role of the IGF Axis and Opportunities for Future Combination Studies
- (2017) Aaron Simpson et al. Targeted Oncology
- Cancer immunoprevention
- (2016) Olivera J Finn et al. CURRENT OPINION IN IMMUNOLOGY
- Immunogenicity and safety of xenogeneic vascular endothelial growth factor receptor-2 DNA vaccination in mice and dogs
- (2016) Sofie Denies et al. Oncotarget
- IGF-1R Inhibition Activates a YES/SFK Bypass Resistance Pathway: Rational Basis for Co-Targeting IGF-1R and Yes/SFK Kinase in Rhabdomyosarcoma
- (2015) Xiaolin Wan et al. NEOPLASIA
- Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice
- (2015) Marianna L Ianzano et al. Oncotarget
- DNA vaccine for cancer immunotherapy
- (2015) Benjamin Yang et al. Human Vaccines & Immunotherapeutics
- Final report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients
- (2014) E. A. Mittendorf et al. ANNALS OF ONCOLOGY
- A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance
- (2014) Alberto S. Pappo et al. CANCER
- Cancer Immunoprevention--The Next Frontier
- (2014) M.-A. D. Smit et al. Cancer Prevention Research
- T-helper I immunity, specific for the breast cancer antigen insulin-like growth factor-I receptor (IGF-IR), is associated with increased adiposity
- (2013) Denise L. Cecil et al. BREAST CANCER RESEARCH AND TREATMENT
- A Multiantigen Vaccine Targeting Neu, IGFBP-2, and IGF-IR Prevents Tumor Progression in Mice with Preinvasive Breast Disease
- (2013) M. L. Disis et al. Cancer Prevention Research
- Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors
- (2013) Claudia Marcela Diaz-Montero et al. Journal of Translational Medicine
- Preclinical HER-2 Vaccines: From Rodent to Human HER-2
- (2013) Pier-Luigi Lollini et al. Frontiers in Oncology
- Human responses against HER-2-positive cancer cells in human immune system-engrafted mice
- (2012) C De Giovanni et al. BRITISH JOURNAL OF CANCER
- A Better Immune Reaction to Erbb-2 Tumors Is Elicited in Mice by DNA Vaccines Encoding Rat/Human Chimeric Proteins
- (2010) Elena Quaglino et al. CANCER RESEARCH
- In silico Modeling and In vivo Efficacy of Cancer-Preventive Vaccinations
- (2010) A. Palladini et al. CANCER RESEARCH
- DNA vaccines against cancer come of age
- (2010) Freda K Stevenson et al. CURRENT OPINION IN IMMUNOLOGY
- The Impact of HER2/neu Expression Level on Response to the E75 Vaccine: From U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02
- (2009) L. C. Benavides et al. CLINICAL CANCER RESEARCH
- Molecular and cellular biology of rhabdomyosarcoma
- (2009) Carla De Giovanni et al. Future Oncology
- A Multi-DNA Preventive Vaccine for p53/Neu-Driven Cancer Syndrome
- (2009) C. De Giovanni et al. HUMAN GENE THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation